Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and …

BM Wei, LP Fox, BH Kaffenberger, AM Korman… - Journal of the American …, 2024 - Elsevier
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …

Drug reaction with eosinophilia and systemic symptoms (DReSS)/Drug-Induced hypersensitivity syndrome (DiHS)—readdressing the DReSS

H Stirton, NH Shear, RP Dodiuk-Gad - Biomedicines, 2022 - mdpi.com
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-
induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug …

[HTML][HTML] Renal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review of 71 cases

M Dagnon da Silva, SM Domingues, S Oluic… - Journal of Clinical …, 2023 - mdpi.com
JCM | Free Full-Text | Renal Manifestations of Drug Reaction with Eosinophilia and Systemic
Symptoms (DRESS) Syndrome: A Systematic Review of 71 Cases Next Article in Journal …

Role of endomyocardial biopsy in diagnostics of myocarditis

L Vidusa, O Kalejs, A Maca-Kaleja, I Strumfa - Diagnostics, 2022 - mdpi.com
Endomyocardial biopsy as the cornerstone of diagnostics has been re-evaluated throughout
the years, leaving unanswered questions on the precedence of it. The reported incidence of …

Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: a disproportionality analysis

A Sharma, A Kumar - Acta Neurologica Scandinavica, 2022 - Wiley Online Library
Objectives Clobazam is a well‐known benzodiazepine used as an anti‐anxiety drug as well
as an anti‐epileptic, particularly for patients who are not responding to first‐line treatments …

Biomarkers in acute myocarditis and chronic inflammatory cardiomyopathy: an updated review of the literature

G Crisci, E Bobbio, P Gentile, DI Bromage… - Journal of Clinical …, 2023 - mdpi.com
Myocarditis is a disease caused by cardiac inflammation that can progress to dilated
cardiomyopathy, heart failure, and eventually death. Several etiologies, including …

Immune checkpoint inhibitors-associated myocarditis: diagnosis, treatment and current status on rechallenge

F Frascaro, N Bianchi, F Sanguettoli, F Marchini… - Journal of Clinical …, 2023 - mdpi.com
Immune checkpoint molecules like cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed
cell death 1 (PD-1) or its ligand, programmed cell death ligand 1 (PD-L1), play a critical role …

Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment

R Lasica, L Djukanovic, L Savic, G Krljanac… - Diagnostics, 2023 - mdpi.com
Although the frequency of myocarditis in the general population is very difficult to accurately
determine due to the large number of asymptomatic cases, the incidence of this disease is …

Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review

W Shalata, ZG Attal, R Shhadi, A Abu Salman… - Medicina, 2023 - mdpi.com
Many different types of cancer can be treated with immunotherapy drugs called immune
checkpoint inhibitors (ICIs). These drugs have altered the landscape of cancer treatment …

Demystifying drug reaction with eosinophilia and systemic symptoms (DRESS): a review of the literature and guidelines for management

CL Wedel - Archives of Dermatological Research, 2024 - Springer
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe, adverse drug
reaction that is notoriously complex in both its presentation and treatment. Although early …